CytoSorbents Corp. (CTSO)
0.80
+0.05
(+6.81%)
USD |
NASDAQ |
Mar 03, 16:00
0.7911
-0.01
(-1.11%)
After-Hours: 20:00
CytoSorbents Shareholders Equity (Quarterly) : 9.02M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems, Inc. | 111.22M |
| Quest Diagnostics, Inc. | 7.17B |
| Danaher Corp. | 52.53B |
| Cardiac Biotech Solutions, Inc. | -2.230M |
| Odyssey Health, Inc. | -7.155M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.75M |
| Total Liabilities (Quarterly) | 36.73M |
| Debt to Equity Ratio | 3.040 |
| Current Ratio | 2.108 |
| Net Debt Paydown Yield | -0.22% |